Predicting cancer outcomes with radiomics and artificial intelligence in radiology von Bera, Kaustav, Braman, Nathaniel, Gupta, Amit, Velcheti, Vamsidhar, Madabhushi, Anant

Volltext

State-of-the-Art Strategies for Targeting RET -Dependent Cancers von Subbiah, Vivek, Yang, Dong, Velcheti, Vamsidhar, Drilon, Alexander, Meric-Bernstam, Funda

Volltext

Radiomics and radiogenomics in lung cancer: A review for the clinician von Thawani, Rajat, McLane, Michael, Beig, Niha, Ghose, Soumya, Prasanna, Prateek, Velcheti, Vamsidhar, Madabhushi, Anant

Volltext

Efficacy of Selpercatinib in RET Fusion–Positive Non–Small-Cell Lung Cancer von Drilon, Alexander, Oxnard, Geoffrey R, Tan, Daniel S.W, Loong, Herbert H.F, Johnson, Melissa, Gainor, Justin, McCoach, Caroline E, Gautschi, Oliver, Besse, Benjamin, Cho, Byoung C, Peled, Nir, Weiss, Jared, Kim, Yu-Jung, Ohe, Yuichiro, Nishio, Makoto, Park, Keunchil, Patel, Jyoti, Seto, Takashi, Sakamoto, Tomohiro, Rosen, Ezra, Shah, Manisha H, Barlesi, Fabrice, Cassier, Philippe A, Bazhenova, Lyudmila, De Braud, Filippo, Garralda, Elena, Velcheti, Vamsidhar, Satouchi, Miyako, Ohashi, Kadoaki, Pennell, Nathan A, Reckamp, Karen L, Dy, Grace K, Wolf, Jürgen, Solomon, Benjamin, Falchook, Gerald, Ebata, Kevin, Nguyen, Michele, Nair, Binoj, Zhu, Edward Y, Yang, Luxi, Huang, Xin, Olek, Elizabeth, Rothenberg, S. Michael, Goto, Koichi, Subbiah, Vivek

Volltext

Real-world outcomes of first-line pembrolizumab plus pemetrexed-carboplatin for metastatic nonsquamous NSCLC at US oncology practices von Velcheti, Vamsidhar, Hu, Xiaohan, Piperdi, Bilal, Burke, Thomas

Volltext

Rational design of anti-GITR-based combination immunotherapy von Zappasodi, Roberta, Sirard, Cynthia, Li, Yanyun, Budhu, Sadna, Abu-Akeel, Mohsen, Liu, Cailian, Yang, Xia, Zhong, Hong, Newman, Walter, Qi, Jingjing, Wong, Phillip, Schaer, David, Koon, Henry, Velcheti, Vamsidhar, Hellmann, Matthew D., Postow, Michael A., Callahan, Margaret K., Wolchok, Jedd D., Merghoub, Taha

Volltext

Spatially Resolved and Quantitative Analysis of VISTA/PD-1H as a Novel Immunotherapy Target in Human Non-Small Cell Lung Cancer von Villarroel-Espindola, Franz, Yu, Xiaoqing, Datar, Ila, Mani, Nikita, Sanmamed, Miguel, Velcheti, Vamsidhar, Syrigos, Konstantinos, Toki, Maria, Zhao, Hongyu, Chen, Lieping, Herbst, Roy S, Schalper, Kurt A

Volltext

Role of immune-checkpoint inhibitors in lung cancer von Jain, Prantesh, Jain, Chhavi, Velcheti, Vamsidhar

Volltext

Differential Expression and Significance of PD-L1, IDO-1, and B7-H4 in Human Lung Cancer von Schalper, Kurt A, Carvajal-Hausdorf, Daniel, McLaughlin, Joseph, Altan, Mehmet, Velcheti, Vamsidhar, Gaule, Patricia, Sanmamed, Miguel F, Chen, Lieping, Herbst, Roy S, Rimm, David L

Volltext

Clinical Characteristics and Outcomes of COVID-19–Infected Cancer Patients: A Systematic Review and Meta-Analysis von Zhang, Hua, Han, Han, He, Tianhui, Labbe, Kristen E, Hernandez, Adrian V, Chen, Haiquan, Velcheti, Vamsidhar, Stebbing, Justin, Wong, Kwok-Kin

Volltext

Spatial Architecture and Arrangement of Tumor-Infiltrating Lymphocytes for Predicting Likelihood of Recurrence in Early-Stage Non-Small Cell Lung Cancer von Corredor, Germán, Wang, Xiangxue, Zhou, Yu, Lu, Cheng, Fu, Pingfu, Syrigos, Konstantinos, Rimm, David L, Yang, Michael, Romero, Eduardo, Schalper, Kurt A, Velcheti, Vamsidhar, Madabhushi, Anant

Volltext

Perinodular and Intranodular Radiomic Features on Lung CT Images Distinguish Adenocarcinomas from Granulomas von Beig, Niha, Khorrami, Mohammadhadi, Alilou, Mehdi, Prasanna, Prateek, Braman, Nathaniel, Orooji, Mahdi, Rakshit, Sagar, Bera, Kaustav, Rajiah, Prabhakar, Ginsberg, Jennifer, Donatelli, Christopher, Thawani, Rajat, Yang, Michael, Jacono, Frank, Tiwari, Pallavi, Velcheti, Vamsidhar, Gilkeson, Robert, Linden, Philip, Madabhushi, Anant

Volltext

Dabrafenib in combination with trametinib in the treatment of patients with BRAF V600-positive advanced or metastatic non-small cell lung cancer: clinical evidence and experience von Khunger, Arjun, Khunger, Monica, Velcheti, Vamsidhar

Volltext

Objective measurement and clinical significance of TILs in non-small cell lung cancer von Schalper, Kurt A, Brown, Jason, Carvajal-Hausdorf, Daniel, McLaughlin, Joseph, Velcheti, Vamsidhar, Syrigos, Konstantinos N, Herbst, Roy S, Rimm, David L

Volltext

Blood-based tumor mutational burden as a biomarker for atezolizumab in non-small cell lung cancer: the phase 2 B-F1RST trial von Kim, Edward S., Velcheti, Vamsidhar, Mekhail, Tarek, Yun, Cindy, Shagan, Sarah M., Hu, Sylvia, Chae, Young Kwang, Leal, Ticiana A., Dowell, Jonathan E., Tsai, Michaela L., Dakhil, Christopher S. R., Stella, Philip, Jin, Yanling, Shames, David S., Schleifman, Erica, Fabrizio, David A., Phan, See, Socinski, Mark A.

Volltext

Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non-Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis von Datar, Ila, Sanmamed, Miguel F, Wang, Jun, Henick, Brian S, Choi, Jungmin, Badri, Ti, Dong, Weilai, Mani, Nikita, Toki, Maria, Mejías, Luis D, Lozano, Maria D, Perez-Gracia, Jose Luis, Velcheti, Vamsidhar, Hellmann, Matthew D, Gainor, Justin F, McEachern, Kristen, Jenkins, David, Syrigos, Konstantinos, Politi, Katerina, Gettinger, Scott, Rimm, David L, Herbst, Roy S, Melero, Ignacio, Chen, Lieping, Schalper, Kurt A

Volltext

Evaluation of PD-L1 Expression and Associated Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma von Vassilakopoulou, Maria, Avgeris, Margaritis, Velcheti, Vamsidhar, Kotoula, Vassiliki, Rampias, Theodore, Chatzopoulos, Kyriakos, Perisanidis, Christos, Kontos, Christos K, Giotakis, Aris I, Scorilas, Andreas, Rimm, David, Sasaki, Clarence, Fountzilas, George, Psyrri, Amanda

Volltext

Prediction of recurrence in early stage non-small cell lung cancer using computer extracted nuclear features from digital H&E images von Wang, Xiangxue, Janowczyk, Andrew, Zhou, Yu, Thawani, Rajat, Fu, Pingfu, Schalper, Kurt, Velcheti, Vamsidhar, Madabhushi, Anant

Volltext

Real-world PD-L1 testing and distribution of PD-L1 tumor expression by immunohistochemistry assay type among patients with metastatic non-small cell lung cancer in the United State... von Velcheti, Vamsidhar, Patwardhan, Pallavi D, Liu, Frank Xiaoqing, Chen, Xin, Cao, Xiting, Burke, Thomas

Volltext

Sarcomatoid Lung Carcinomas Show High Levels of Programmed Death Ligand-1 (PD-L1) von Velcheti, Vamsidhar, Rimm, David L., Schalper, Kurt A.

Volltext